GHK-Cu, by contrast, has only preclinical (laboratory and animal) evidence and has not been validated in large-scale human trials
Short-chain fatty acids, particularly butyrate and propionate, have been shown to activate receptors on enteroendocrine L-cells, triggering GLP-1 release
If you have a sensitive digestive system or want the fastest possible support, a liquid is usually the best bet
Although the results suggest that KD exacerbates biotin deficiency in mice, human clinical studies are needed to confirm these observations (249)
Compounding of another big-selling GLP-1 drug Eli Lilly's tirzepatide was blocked in December after that also came off the shortage list
The responsible takeaway is that topical GHK-Cu has a reassuring but not exhaustively proven safety record, while systemic use is genuinely under-studied in humans